6.55
+0.03(+0.46%)
Currency In USD
Address
700 Chesapeake Drive
Redwood City, CA 94063
United States of America
Phone
650 364 0400
Website
Sector
Healthcare
Industry
Medical - Devices
Employees
279
First IPO Date
October 01, 2020
| Name | Title | Pay | Year Born |
| Mr. Steven S. Williamson | Chief Executive Officer, President & Director | 0 | 1973 |
| Mr. Geoffrey Beran Rose | Chief Commercial Officer | 632,293 | 1974 |
| Mr. David A. Lehman J.D. | General Counsel & Secretary | 651,389 | 1961 |
| Mr. Mehul Joshi | Chief Financial Officer | 0 | 1961 |
| Mr. John B. McKune | Vice President & Corporate Controller | 0 | 1976 |
| Mr. Sri Radhakrishnan | Chief Technical Officer | 0 | N/A |
| Ms. Marcee M. Maroney | Vice President of Marketing | 0 | 1970 |
| Sarah Huber | Vice President of Sales (U.S.) | 0 | N/A |
| Ms. Lisa Paul | Chief People Officer | 0 | 1964 |
| Mr. Jérôme Erath | Senior Vice President & GM of Europe Middle-East & Africa | 0 | N/A |
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also provides StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. It serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.